Plasmacytosis is one of the most common histologic findings in the lymph node biopsy evaluation. We retrospectively reviewed lymph node biopsy cases from our institution. We analyzed a large series of lymphadenopathy cases to compare histologic, immunophenotypic, and clinical features of benign reactive plasmacytosis vs malignant plasma cell neoplasms. We identified 106 cases that showed features of follicular hyperplasia with interfollicular plasmacytosis. These cases were morphologically subdivided into four groups with additional specific findings including florid reactive follicular hyperplasia (FRFH), marginal zone hyperplasia (MZH), Castlemanlike morphology, and a diffuse pattern with cytological atypia. The most common etiology was FRFH with interfollicular plasmacytosis and was observed in a majority of cases (68%). Most of these cases were accompanied with several reactive immunological abnormalities (rheumatoid arthritis, SLE, Epstein-Barr virus, or human immunodeficiency virus infections, IgG4 disease, and plasma cell variant of Castleman disease). Of all the cases, 12 also presented with systemic polytypical plasmacytosis, which was found to be associated with currently ill-defined clinicopathological entities that we categorized as autoimmune diseases. Of note, the cases with IgG4 disease exhibited patchy, uneven distribution of IgG4-positive plasma cells with expansion of intrafollicular plasma cells and perifollicular fibrosis. The cases with cytological atypia (32%) and clonality of restrictive immunoglobulin light chain either by flow cytometry, immunohistochemistry, or in situ hybridization were further classified as plasmacytoma, marginal zone lymphoma, lymphoplasmacytic lymphoma, diffuse large B-cell lymphoma with plasmacytic differentiation or plasmablastic lymphoma. Histologic identification of immature plasma cell differentiation, mitotic figures, Dutcher body, immunophenotypical aberrancy by flow cytometry in the plasma cells (CD19-, CD56+, CD33+, or CD117+) are important features for distinguishing plasma cell tumors from reactive conditions. Therefore, it is important to identify malignant clonal plasmacytosis by integration of morphologic, immunophenotypic, immunofixation, radiologic, and cytogenetic findings. Introduction: Lymph node necrosis/infarction is not a rare event and may be the presenting manifestation for malignant lymphoma. However, accurate diagnosis is difficult and sometimes impossible when biopsy tissue has extensive necrosis. Moreover, there is conceptual belief that immunohistochemistry studies are not sensitive nor specific for the necrotic tissue. The purpose of this study is to emphasize the importance of methodical analysis of the suboptimal/necrotic tissue using a combined histologic and limited immunohistochemistry study that can aid in establishing lymphoma diagnosis. Design: Lymph node biopsies of three adult cases showing extensive coagulative necrosis/infarction. Histomorphologic evaluation of paraffin-embedded tissue together with immunohistochemistry studies is performed. Results: Cases 1 and 2 show small patchy areas of small lymphocyte-dominant infiltrate in a background of extensive fibrosis and necrosis. Case 3 shows coagulative necrosis with peripheral reactive appearing lymph node tissue. All cases show preservation of CD20 in a diffuse pattern and scattered CD3 positive T-lymphocytes in necrotic areas. The residual viable lymphocytic infiltrate shows atypical immunophenotypes, such as monotypic light chain expression in a minute plasmablastic focus (case 1), CD10-/BCL6+/MUM1+ in small aggregates of atypical large lymphocytes (case 2) and mixed reactive and atypical lymphocytes (case 3). Subsequent biopsies performed for cases 2 and 3 at different intervals showed diffuse large B-cell lymphoma.
Conclusion:
The work-up for infarcted lymph node is challenging because of the suboptimal histomorphologic evaluation. A diffuse sheet of CD20 reactivity in monotonous appearing ghost cells with scattered T-lymphocytes is very suggestive of necrotic lymphoma. Additional immunohistochemical studies to characterize the background lymphocytic infiltrate should be pursued and sometimes yield valuable diagnostic information. Spontaneous necrosis in malignant lymphoma is usually related to high stage and aggressive behavior. Therefore, recognizing this pitfall, using methodical analysis to establish such a diagnosis in a timely manner is pivotal to prevent delay in proper disease treatment.
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Expression of Estrogen Receptor Beta (ER[beta]) in Low Grade B-Cell Lymphomas: An Immunohistochemical Study
Lagnajita Datta, Kedar Inamdar, MD, PhD, Madhu Menon, MD, PhD; Henry Ford Hospital, Detroit, MI
Introduction: Most lymphoid malignancies are associated with higher incidence and poorer prognosis in men than women. Epidemiological data associate reproductive hormones and oral contraceptives with reduced risk in women, attributed to estrogen. Estrogen's action is mediated by two nuclear receptors, estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ), with different tissue distribution and actions. ERα promotes cell proliferation whereas ERβ shows anti-proliferative effects. Studies show ERβ to be predominantly expressed in lymphoid tissue. There is a dearth of studies about expression of ERβ in lymphoid malignancies. Hence, we characterized the expression of ERβ in low grade B-cell lymphomas by immunohistochemistry in men and women. Methods and Materials: Low-grade B-cell lymphomas diagnosed between 2006 and 2016 were retrieved from archives. ERβ immunostaining was performed on formalin-fixed paraffin-embedded sections of 45 lymphoma cases with typical histology, flow cytometry, and cytogenetics: 10 chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) (six men, four women), nine mantle cell lymphomas (five men, four women), 10 marginal zone lymphomas (four men, six women), eight follicular lymphomas (four men, four women), four classical (two men, two women), and four nodular lymphocyte predominant (two men, two women) Hodgkin lymphomas. Control tissue from tonsils, lymph nodes, and spleen were also immunostained. Results: Immunohistochemical ERβ staining of tonsils and lymph nodes in men and women show strong nuclear staining of lymphocytes in the germinal and mantle zone of the lymphoid follicles as compared to the paracortical region. The white pulp (periarteriolar lymphatic sheath) and red pulp in spleen show strong ERβ positivity. Strong nuclear staining of lymphocytes was seen in all cases of CLL/SLL, mantle, marginal, follicular, and Hodgkin lymphomas. No difference in staining was seen between men and women in normal lymphoid and lymphoma specimens. Conclusion: All low-grade B-cell lymphomas strongly express ERβ in men and women, highlighting role of estrogens in pathogenesis. Since estrogen concentrations are higher in women, this might explain the sex predilection and poorer prognosis in men. Also, these results raise the possibility of using ERβ agonists as a novel therapeutic agent in these lymphomas.
Cytogenetic Aberrations in Young Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Guanghong Liao, MD, Sujata Sajjan, MD, Tianyu Yang, MD, Silvat Sheikh-Fayyaz, MD, Nina Haghi, MD, Xinmin Zhang, Jing Wang, Brian Chen, Judith Brody, Kalpana Reddy, MD, Peihong Hsu, MD; Northwell Health, Great Neck, NY Objectives: Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) is a low-grade B-cell hematologic malignancy with high global prevalence. Half the patients have somatic mutations, as demonstrated by fluorescence in situ hybridization (FISH) interphase analysis in over 80% of these cases. Del 11q22-23, TP53/17p deletion and del 6q are clinically significant high-risk prognostic factors. Few studies show that 10%-20% of patients are younger than 55 years, and their prognosis differs from older patients because of their longer survival. Methods: We retrospectively reviewed FISH studies in 800 patients with CLL/SLL diagnosed in our health system during years [2003] [2004] [2005] [2006] [2007] [2008] [2009] [2010] [2011] [2012] [2013] [2014] [2015] [2016] . Results: A total of 120 patients (15%) are identified as younger than 55 years at first diagnosis with ages ranging from 31 to 55 (median age of 51). FISH results are available in 53 young patients and 167 older patients. Molecular aberrations found in the younger age group compared to older group are as follows: deletions at LAMP1/13q14 (35.8% vs 43.1%, P = .22), CEP12/trisomy 12 (26.4% vs 25.1%, P = .45), deletions of ATM/11q22-23 (16.9% vs 20.3%, P = .37), TP53/17p13 deletion (9.4% vs 17.9%, P = .1), and MYB/6q deletion (5.6% vs 4.8%, P = .55). Conclusion: Our study in younger patients demonstrates lower frequency of cytogenetic aberrations of 11q deletion and TP53/17p deletion, which are typically worse prognostic predictors of CLL/SLL. Although the changes are not statistically significant, this finding may contribute to the better outcomes of the younger patient group. More patients, additional data, and longer follow-up are necessary to determine the importance of these findings.
